Neko Health Launched Commercial Body Scans in the U.S.

The firm introduced its $499 health monitoring service, though industry groups warn of limited medical consensus.

Updated on Oct. 6, 2026 in Healthcare

Neko Health Launched Commercial Body Scans in the U.S.

Live Poll

Do you trust commercial full-body health scans to provide useful medical insights?

Neko Health has expanded its full-body scan service into the United States, offering health assessments for $499. The service utilizes 2D cameras, thermal cameras, and depth sensors to analyze biomarkers alongside skin and blood tests.

Why it matters

Operators in the wellness and healthcare sectors should note that Neko Health aims to address high-burden disease areas through data collection. However, the service faces scrutiny as major medical associations have not endorsed these commercial scans, calling for additional research.

Neko Health set the cost for its signature, one-hour scan at $499, which is now available in the U.S. beyond its existing markets in Sweden and the United Kingdom.

The players

Neko Health

A health technology firm providing non-diagnostic body scans that collect biomarker and sensor data.

American Medical Association

A national professional organization that establishes ethical and clinical standards for physicians.

The details

The scan process takes approximately one hour to complete and is designed to collect data across health areas with a high burden of disease. Neko Health uses a combination of 2D cameras, thermal cameras, and depth sensors paired with blood and skin analysis. The service explicitly does not provide MRI or CT imaging of internal organs, differentiating it from traditional diagnostic imaging pathways.

Timeline

  1. October 6, 2026: Article publication date.

  2. 2026: JAMA published an editorial regarding commercial body scans.

Market Landscape

This service launch navigates a cautious regulatory and clinical environment defined by the American Medical Association stance on commercial body imaging. The company enters the U.S. market as industry stakeholders continue to debate the diagnostic value versus the potential for over-testing.

Business owners in wellness should evaluate the potential for increased customer demand for preventative health tracking versus the lack of institutional medical endorsement. Monitor how liability or insurance considerations evolve as non-clinical scanning services become more prevalent.

The takeaway

Commercial health monitoring services are expanding, but operators must reconcile the high cost of entry with the skepticism currently held by major medical associations. Track the ongoing discourse in journals like JAMA to gauge whether these scans move toward wider clinical acceptance.

Further reading

For broader trends in wellness and medical service innovations, see Healthcare.

Source note: This article includes information reported by Women's Health.

Live Poll

Do you trust commercial full-body health scans to provide useful medical insights?